Valeant Lays Off 77 Dendreon Workers in Seattle

Mar 03, 2015

The Seattle Times

Valeant Pharmaceuticals International is laying off 77 employees at Seattle-based Dendreon’s operations, according to a WARN notice received by the state Employment Security Department.

An article in The Seattle Times said the layoffs began Feb. 23, immediately after completion of the $495 million sale of Dendreon’s prostate cancer drug, Provenge, and other assets.

The article went on to say that Valeant spokeswoman Laurie Little said, “most of these positions were in G&A functions where there was overlap with Valeant’s existing businesses, especially in corporate and back office functions.”

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments